Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy
-
Published:2020
Issue:2
Volume:9
Page:207-220
-
ISSN:2235-1795
-
Container-title:Liver Cancer
-
language:en
-
Short-container-title:Liver Cancer
Author:
Tseng Tai-Chung, Peng Cheng-Yuan, Hsu Yao-Chun, Su Tung-Hung, Wang Chia-Chi, Liu Chun-Jen, Yang Hung-Chih, Yang Wan-Ting, Lin Chia-Hsin, Yu Ming-Lung, Lai Hsueh-Chou, Tanaka Yasuhito, Nguyen Mindie H., Liu Chen-Hua, Chen Pei-Jer, Chen Ding-Shinn, Kao Jia-HorngORCID
Subject
Oncology,Hepatology
Reference40 articles.
1. Kao JH. Hepatitis B: from control to cure. J Formos Med Assoc. 2018 Oct;117(10):868–70. 2. Wong GL, Chan HL, Mak CW, Lee SK, Ip ZM, Lam AT, et al. Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis. Hepatology. 2013 Nov;58(5):1537–47. 3. Su TH, Hu TH, Chen CY, Huang YH, Chuang WL, Lin CC, et al.; C-TEAM study group and the Taiwan Liver Diseases Consortium. Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients. Liver Int. 2016 Dec;36(12):1755–64. 4. Wong VW, Janssen HL. Can we use HCC risk scores to individualize surveillance in chronic hepatitis B infection? J Hepatol. 2015 Sep;63(3):722–32. 5. Tseng TC, Liu CJ, Su TH, Yang WT, Chen CL, Yang HC, et al. Fibrosis-4 Index Helps Identify HBV Carriers With the Lowest Risk of Hepatocellular Carcinoma. Am J Gastroenterol. 2017 Oct;112(10):1564–74.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|